MedPath

Bracco Diagnostics, Inc.

🇺🇸United States
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://imaging.bracco.com/us-en

Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-142

Phase 3
Completed
Conditions
Coronary Artery Disease
Interventions
First Posted Date
2015-09-17
Last Posted Date
2021-07-07
Lead Sponsor
Bracco Diagnostics, Inc
Target Recruit Count
174
Registration Number
NCT02552238
Locations
🇧🇪

Cliniques Universitaires Saint-Luc Unité de Pathologie Cardio-Vasculaire / Cardiologie, Bruxelles, Belgium

🇧🇪

Antwerp University Hospital, Edegem, Belgium

🇺🇸

Ochsner Clinic Foundation, New Orleans, Louisiana, United States

and more 10 locations

Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-141

Phase 3
Completed
Conditions
Coronary Artery Disease
Interventions
First Posted Date
2015-08-13
Last Posted Date
2021-06-11
Lead Sponsor
Bracco Diagnostics, Inc
Target Recruit Count
175
Registration Number
NCT02522481
Locations
🇺🇸

University of California San Diego, La Jolla, California, United States

🇺🇸

Community Heart and Vascular Community Hospital East, Indianapolis, Indiana, United States

🇺🇸

North Kansas City Hospital, North Kansas City, Missouri, United States

and more 14 locations

Retrospective Study of MRI in Pediatric Patients

Completed
Conditions
Central Nervous System Disease
Central Nervous System Neoplasms
First Posted Date
2014-11-17
Last Posted Date
2016-07-19
Lead Sponsor
Bracco Diagnostics, Inc
Target Recruit Count
90
Registration Number
NCT02291822

Evaluation of Safety and Efficacy of Lumason in Pediatric Echocardiography

Phase 3
Terminated
Conditions
Heart Disease
Interventions
Drug: sulphur hexafluoride lipid-type A microspheres
First Posted Date
2014-11-04
Last Posted Date
2020-07-13
Lead Sponsor
Bracco Diagnostics, Inc
Target Recruit Count
13
Registration Number
NCT02282163
Locations
🇺🇸

Washington University School of Medicine in Saint Louis, Saint Louis, Missouri, United States

🇺🇸

University of Nebraska, Omaha, Nebraska, United States

A Pilot Trial Using BR55 Ultrasound Contrast Agent in the Assessment of Prostate Cancer

Phase 1
Completed
Conditions
Prostate Cancer
Interventions
First Posted Date
2014-05-20
Last Posted Date
2021-03-29
Lead Sponsor
Bracco Diagnostics, Inc
Target Recruit Count
19
Registration Number
NCT02142608
Locations
🇺🇸

Translational Molecular Imaging Lab, Stanford, California, United States

🇫🇷

Service d'Imagerie Diagnostique et Interventionnelle de l'Adulte, Bordeaux, France

Crossover Comparison of MultiHance and Dotarem

Phase 4
Completed
Conditions
Brain Disease
Interventions
First Posted Date
2014-02-25
Last Posted Date
2017-01-10
Lead Sponsor
Bracco Diagnostics, Inc
Target Recruit Count
179
Registration Number
NCT02070380
Locations
🇺🇸

Samaritan Health Services, Corvallis, Oregon, United States

Multidetector Computed Tomography (MDCT) Tailored Protocol

Completed
Conditions
Patients Undergoing Contrast Enhanced Multidetector Computed Tomography of the Chest, Abdomen, Liver or Aorta for Any Diagnostic Cause
First Posted Date
2012-11-29
Last Posted Date
2013-09-30
Lead Sponsor
Bracco Diagnostics, Inc
Target Recruit Count
1493
Registration Number
NCT01737333
Locations
🇮🇹

Oepedale Niguarda, Milan, Italy

🇺🇸

Department of Radiology Carolinas Medical Center, Charlotte, North Carolina, United States

Comparison of Prohance® With Gadovist®/Gadavist™ in Magnetic Resonance Imaging (MRI) of the Brain

Phase 4
Completed
Conditions
Brain Disease
Interventions
First Posted Date
2012-06-07
Last Posted Date
2015-07-01
Lead Sponsor
Bracco Diagnostics, Inc
Target Recruit Count
229
Registration Number
NCT01613417
Locations
🇺🇸

Holy Name Medical Center, Teaneck, New Jersey, United States

Prospective Evaluation of Strontium in Patients After CardioGen-82 PET MPI Scanning at Two Clinical Sites

Completed
Conditions
Radiation Exposure
First Posted Date
2011-09-09
Last Posted Date
2012-04-25
Lead Sponsor
Bracco Diagnostics, Inc
Target Recruit Count
72
Registration Number
NCT01430975
Locations
🇺🇸

Bracco Diagnostics, Inc., Princeton, New Jersey, United States

Prospective Evaluation of Strontium in Patients After CardioGen-82 PET MPI Scanning

Completed
Conditions
Radiation Exposure
First Posted Date
2011-08-29
Last Posted Date
2012-08-15
Lead Sponsor
Bracco Diagnostics, Inc
Target Recruit Count
155
Registration Number
NCT01424774
Locations
🇺🇸

Bracco Diagnostics, Inc., Princeton, New Jersey, United States

© Copyright 2025. All Rights Reserved by MedPath